Evidence map›Paper›PMID 35844505›Full record

ReviewFrontiers in immunology2022

Nanomaterial-Based Zinc Ion Interference Therapy to Combat Bacterial Infections.

Yongbin Wei, Jiaming Wang, Sixuan Wu, Ruixue Zhou, Kaixiang Zhang, Zhenzhong Zhang, Junjie Liu, Shangshang Qin, Jinjin Shi

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Beyond Bactericidal: Plasma Surface Engineering to Defeat Food Matrix-Conditioning Layers.Comprehensive reviews in food science and food safety · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yongbin WeiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Jiaming WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Sixuan WuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Ruixue ZhouSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Kaixiang ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Zhenzhong ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Junjie LiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Shangshang QinSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Jinjin ShiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenic bacterial infections are the second highest cause of death worldwide and bring severe challenges to public healthcare. Antibiotic resistance makes it urgent to explore new antibacterial therapy. As an essential metal element in both humans and bacteria, zinc ions have various physiological and biochemical functions. They can stabilize the folded conformation of metalloproteins and participate in critical biochemical reactions, including DNA replication, transcription, translation, and signal transduction. Therefore, zinc deficiency would impair bacterial activity and inhibit the growth of bacteria. Interestingly, excess zinc ions also could cause oxidative stress to damage DNA, proteins, and lipids by inhibiting the function of respiratory enzymes to promote the formation of free radicals. Such dual characteristics endow zinc ions with unparalleled advantages in the direction of antibacterial therapy. Based on the fascinating features of zinc ions, nanomaterial-based zinc ion interference therapy emerges relying on the outstanding benefits of nanomaterials. Zinc ion interference therapy is divided into two classes: zinc overloading and zinc deprivation. In this review, we summarized the recent innovative zinc ion interference strategy for the treatment of bacterial infections and focused on analyzing the antibacterial mechanism of zinc overloading and zinc deprivation. Finally, we discuss the current limitations of zinc ion interference antibacterial therapy and put forward problems of clinical translation for zinc ion interference antibacterial therapy.

Indexed as

Bacterial InfectionsNanostructuresAnti-Bacterial AgentsBacteriaHumansIonsZincAnti-Bacterial AgentsIonsZincantibacterial therapeuticsnanomaterialstargeted delivery technologyzinc homeostasiszinc ion interference

Identifiers

PMID35844505
PMCPMC9279624
OpenAlexW4283751790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.